<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Efficacy of a Chinese Herbal Medicine Compound Zhangpi Ointment against Hydroxyurea-Induced Leg Ulcers: A Prospective, Randomized, Open-Label, Controlled Clinical Trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-12-12">12 December 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Yu-Yang</forename><surname>Pang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yan</forename><surname>Li</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Traditional Chinese Medicine</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gang</forename><surname>Kui</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Traditional Chinese Medicine</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yong</forename><surname>Tang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ming-Juan</forename><surname>Liao</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Traditional Chinese Medicine</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yong-Ling</forename><surname>Wang</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Traditional Chinese Medicine</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhen-Dong</forename><surname>Cao</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Traditional Chinese Medicine</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qi</forename><surname>Zhu</surname></persName>
							<idno type="ORCID">0000-0003-3189-2964</idno>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology</orgName>
								<orgName type="institution" key="instit1">Shanghai Ninth People&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<postCode>200011</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Efficacy of a Chinese Herbal Medicine Compound Zhangpi Ointment against Hydroxyurea-Induced Leg Ulcers: A Prospective, Randomized, Open-Label, Controlled Clinical Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-12-12">12 December 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">9BE77424990CA136292EE04991FDC40F</idno>
					<idno type="DOI">10.1155/2018/9329465</idno>
					<note type="submission">Received 4 July 2018; Accepted 23 October 2018;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:18+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objective.</s><s>The randomized controlled trial was to evaluate the efficacy of topical Chinese herbal Zhangpi Ointment for hydroxyureainduced leg ulcers in patients with myeloproliferative neoplasms.</s><s>Patients and Methods.</s><s>This single-center, prospective, randomized, open-label, controlled clinical trial conducted at Shanghai Ninth People's Hospital enrolled 54 patients with hydroxyurea-induced leg ulcers.</s><s>Patients were randomly assigned to the control group (n = 27) treated with chlorhexidine dressing or the intervention group (n = 27) treated with the Zhangpi Ointment.</s><s>Finally, 26 patients in the control group and 23 patients in the intervention group completed 8 weeks of observation.</s><s>Results.</s><s>The rate of complete healing was 100% for the intervention group, which was significantly higher than that of the control group (96.15%) (P&lt;0.05).</s><s>Furthermore, the intervention group achieved a significantly higher rate of wound healing (95.56%) than the control group (69.02%) at week 4 (P&lt;0.01).</s><s>The intervention group took 34 ¬± 5 days to achieve complete healing while the control group took 41 ¬± 7 days (P &lt; 0.01).</s><s>Moreover, grade 3/4 side effects were observed in neither group.</s><s>Conclusion.</s><s>The Zhangpi Ointment is effective in promoting the healing of hydroxyurea-induced leg ulcers in patients with myeloproliferative neoplasms, providing a therapeutic option for a condition that is recalcitrant to conventional therapy.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Myeloproliferative neoplasms (MPNs) are a group of stem cell disorders characterized by clonal myeloproliferation that is devoid of dyserythropoiesis, granulocytic dysplasia, or monocytosis.</s><s>Hydroxyurea (HU) is an S-phase specific chemotherapeutic agent which inhibits DNA synthesis through its action on ribonucleotide diphosphate reductase <ref type="bibr" target="#b0">[1]</ref> and is widely used in the treatment of MPNs.</s><s>Although HU is relatively well tolerated, adverse effects often occur in 9% of treated patients <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Rare and severe adverse effects appear to be associated with long-term administration and may be systemic or restricted to skin and mucous membranes <ref type="bibr" target="#b3">[4]</ref>.</s><s>The occurrence of painful leg ulcers represents another rare and incompletely characterized complication that has been described in patients with myeloproliferative diseases receiving high-dose (mean dose 28.2 mg/kg) and longterm (mean treatment duration 39 months) HU treatment <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>This cutaneous adverse effect is often treatmentresistant, causing delay in healing of the lesion (mean healing duration 4.3 months) <ref type="bibr" target="#b6">[7]</ref>.</s><s>Neovascularization and circulation deficiency and macroerythrocytosis during hydroxyurea treatment may be involved in the development of these rare ulcers, via impairment of the microcirculatory rheology <ref type="bibr" target="#b7">[8]</ref>.</s><s>Poor response to traditional local and systemic therapy is a typical feature of HU-induced leg ulcers, and discontinuation 2 Evidence-Based Complementary and Alternative Medicine of the drug is often required to achieve complete wound healing <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>Although discontinuation of treatment is still the option of choice for complete recovery <ref type="bibr" target="#b10">[11]</ref>, leg ulcer can recur even after discontinuation of HU treatment <ref type="bibr" target="#b11">[12]</ref>.</s><s>Chlorhexidine diacetate released from wound dressing was used as an antimicrobic drug for the treatment of wound including skin ulcers <ref type="bibr" target="#b12">[13]</ref>.</s><s>It has been reported that two patients were successfully treated with a kind of matrix metalloproteinase modulator which is able to modulate the activity of proteases <ref type="bibr" target="#b13">[14]</ref> and one patient was successfully treated with a topical basic fibroblast growth factor product, leading to rapid improvement within 2 weeks, without adverse effects <ref type="bibr" target="#b14">[15]</ref>.</s><s>However, the sample size was too small.</s></p><p><s>Zhangpi Ointment (ZPO) is a mixture of six topical Chinese herbs and two natural minerals, which include Glycyrrhiza uralensis Fisch, Angelica sinensis (Oliv.)</s><s>Diels, Arnebia euchroma (Royle) Johnst., Rheum officinale Baill, Rehmannia glutinosa Libosch, Cortex Lycii, rubber powder, and calomel.</s><s>Licoflavone, a component of Glycyrrhiza uralensis Fisch, was reported to promote gastric mucosal ulcer healing in mice by regulating inflammatory mediators <ref type="bibr" target="#b15">[16]</ref>.</s><s>Gastric ulcer healing effect has also been described for Angelica sinensis (Oliv.)</s><s>Diels and other herbs <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s>These findings, however, were mostly based on the effects of the medicinal herbs on gastrointestinal mucosal ulcers and in rodent models.</s><s>No studies have been carried out on the effects of these medicinal herbs on leg ulcers and in humans.</s></p><p><s>Our anecdotal clinical experience suggests that the ZPO may be effective in promoting healing of HU-induced leg ulcers.</s><s>In the current prospective randomized controlled trial, we sought to investigate the efficacy of the ZPO for HUinduced leg ulcers in 54 patients with MPNs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Trial Design and Participants.</head><p><s>The study protocol was designed by experts from Department of Hematology and Traditional Chinese Medicine, Shanghai Ninth People's Hospital.</s><s>Study approval was obtained from ethics committees at our hospital.</s><s>They were responsible for the training and guidance of investigators and oversaw all aspects of coordination and data collection.</s><s>Records of the allocation details were kept at our hospital for data verification and checking at monitoring visits.</s><s>The study was undertaken in accordance with the Declaration of Helsinki and registered at http://www.chictr.org.cn</s><s>(Clinical Trials.</s><s>Gov ID: ChiCTR-INR-16009001).</s></p><p><s>This was a single-center, prospective, randomized, openlabel, controlled clinical trial of ZPO versus chlorhexidine dressing for HU-induced leg ulcers in patients with MPNs.</s><s>We recruited 71 patients from Shanghai Ninth People's Hospital between July 2016 and April 2018.</s><s>Eligible patients were aged at least 18 years and no older than 70 years, had histologically or cytologically confirmed MPNs which were treated with HU, and had grade 1 to 3 leg ulcer (Wagner's classification) that had persisted for at least 2 months.</s><s>Patients who had severe infection or autoimmune disease, severe liver, kidney, cardiovascular and mental diseases, diabetes, severe malnutrition, or history of bleeding disorder were excluded.</s><s>Enrolled patients who had severe adverse events, who had poor compliance, and who asked for withdrawal were eliminated.</s><s>All patients provided written informed consent.</s></p><p><s>The primary objective was to compare rate of complete healing with co-primary analyses of ulcer improvement (changes in the area of the ulcer) and healing time (number of days taken to achieve complete wound healing).</s><s>Secondary endpoint was adverse events which were evaluated and graded according to Common Terminology Criteria for Adverse Events (NCICTCAE 4.0).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Procedures.</head><p><s>Based on our preliminary experimental results, the rate of complete healing of the intervention group and control group at the fourth week was 95% and 64%, respectively.</s><s>Accordingly, in this superiority trial, the sample size was 54 (with = 0.05, two-tailed and = 0.2).</s><s>All eligible patients were randomly assigned on a 1:1 basis to receive either ZPO or chlorhexidine dressing with standard wound care.</s><s>Randomization lists were generated through http://www.randomizer.org</s><s>and held at our hospital.</s></p><p><s>The pharmacological properties of ZPO are shown in Table <ref type="table" target="#tab_0">1</ref>.</s><s>ZPO was manufactured by the pharmacy of our hospital by the standard preparation method of traditional Chinese ointment medicine.</s><s>The entire process was carried out in a bacteria-free environment and with strict quality control.</s></p><p><s>Standard wound care included local debridement of necrotic tissue or callus and dressing changes once daily until the wounds were completely healed <ref type="bibr" target="#b18">[19]</ref>.</s><s>All wounds were cleansed with sterile saline prior to assessment and dressing application.</s><s>ZPO (about 1 mm thick) was applied to the surface of the ulcer which was then covered by a sterile dressing.</s><s>For the control group, chlorhexidine dressing was applied to the surface of the ulcer directly.</s><s>The duration of follow-up was 8 weeks and every patient was followed up once a week.</s><s>Changes in the area of the ulcer (cm 2 ) were assessed at each follow-up visit.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Statistical Analysis.</head><p><s>Changes in the area of the ulcer (cm 2 ) were measured by digital photography on day 0 and at each follow-up visit and calculated using the Image-Pro 5 Plus 6.0 (Media Cybernetics, Inc., Bethesda, MD, USA ) analysis software.</s><s>The rate of wound healing was calculated according to the following formula: area healed (%) = (initial area -the residual wound area) / initial area √ó 100%.</s><s>The rate of complete healing was defined as the percentage of patients who had complete (100%) healing: complete healing (%) = number of patients who had complete healing / total number of patients √ó 100%.</s><s>Pathological scar formation was assessed according to the Vancouver Scar Scale <ref type="bibr" target="#b19">[20]</ref>.</s></p><p><s>The efficacy statistical analyses were prespecified and followed the intention-to-treat principle.</s><s>All patients with a baseline assessment and at least one post-baseline assessment were included in analyses.</s><s>Furthermore, patients who were randomized, received at least one treatment, and were assessed for adverse events were included in adverse events analysis.</s><s>Continuous variables were described in mean ¬± standard deviation and were compared between groups by  using the Wilcoxon rank sum test or rank ANCOVA for baseline adjustments.</s><s>Student's t test was used to compare proportions and also to test for heterogeneity within subgroups defined by baseline characteristics.</s><s>A P value &lt; 0.05 was considered statistically significant.</s><s>All calculations were performed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Participant Flow.</head><p><s>The study flowchart is shown in Fig- <ref type="figure">ure</ref> 1. Seventy-one patients who developed leg ulcers after undergoing HU therapy were recruited.</s><s>Ten patients who did not meet the eligibility criteria and 7 patients who declined participation were excluded.</s><s>Finally, 54 patients were enrolled in this clinical trial and were randomly assigned on a 1:1 basis to receive either ZPO or chlorhexidine dressing.</s><s>Two patients lost to follow-up due to poor compliance and three patients asked for withdrawal.</s><s>Consequently, 49 patients were analysed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Patient Demographic and Baseline Characteristics.</head><p><s>The demographic and baseline characteristics of the study population are shown in Table <ref type="table" target="#tab_2">2</ref>.</s><s>The median age of the study population was 44 (range, 24 to 60) years and 61.2% of the patients were male.</s><s>Thirty-five (71.4%) patients were diagnosed with essential thrombocythemia, 9 (18.4%) with polycythemia vera, and 5 (10.2%) with myelofibrosis.</s><s>Moreover, 59.2% of the patients had normal Body Mass Index (BMI).</s><s>Each patient had one ulcer.</s><s>The ulcers were evaluated according to the Wagner's classification and were classified to grade 1 (26.5%),</s><s>grade 2 (42.9%), and grade 3 (30.6%).</s><s>Mean ulcer area was 3.5¬±1.0</s><s>(cm 2 ).</s><s>We conducted germiculture of the ulcers for all patients and 18.4% of the patients received systemic antibiotic therapy due to staphylococcus aureus infection.</s><s>Meanwhile, most of the patients suffered moderate (57.1%) and severe pain (28.6%).</s><s>All patients received standard doses of HU (15-20 mg/kg, once daily), which was terminated and replaced with recombined human interferon  (3,000,000 units, three times a week) in 37 patients or watchful waiting in 12 patients when painful leg ulcers appeared.</s><s>The median duration of ulcer prior to enrollment was 10 months.</s><s>The two groups were comparable in demographic and baseline characteristics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Outcomes and Estimation.</head><p><s>Forty-nine patients completed 8 weeks of treatment.</s><s>The rate of complete healing was 100% for the intervention group, which was significantly higher than that of the control group (96.15%) (P &lt; 0.05).</s><s>Statistically significant difference in the rate of complete healing between the intervention group and the control group started to emerge at week 4 of treatment (intervention: 26.09% versus control: 6.90%; P &lt; 0.05) (Figure <ref type="figure" target="#fig_2">2</ref>).</s><s>Furthermore, the intervention group achieved a significantly higher rate of wound healing (95.56%) than the control group (69.02%) at week 4 (P &lt; 0.01) (Figure <ref type="figure">3</ref>).</s><s>The intervention group took 34 ¬± 5 days to achieve complete healing while the control group took 41 ¬±7 days (P &lt; 0.01) (Figure <ref type="figure" target="#fig_4">4</ref>).</s><s>Moreover, the number of pathological scars was significantly smaller in the intervention group than the control group (P &lt; 0.01) (Figure <ref type="figure" target="#fig_6">5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">Adverse Events.</head><p><s>Adverse events were evaluated and graded according to Common Terminology Criteria for    Adverse Events (NCICTCAE 4.0).</s><s>Table <ref type="table" target="#tab_3">3</ref> shows the frequency of common side effects.</s><s>Grade 3/4 side effects were observed in neither group, and no patients withdrew due to side effects.</s><s>Grade 2 dry skin and skin tenderness, and grade 1 liver disorder were seen in 1 patient each in the intervention group.</s><s>Grade 2 liver disorder was seen in 1 patient in the control group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>HU-induced leg ulcers, though rare, are recalcitrant to treatment and mandate cessation of HU therapy <ref type="bibr" target="#b20">[21]</ref>.</s><s>The  present randomized trial showed that the Chinese medicinal herbal ZPO was effective in promoting the healing of HUinduced leg ulcers, providing an alternative treatment for the disease.</s></p><p><s>HU remains the therapeutic choice for myeloproliferative neoplasms such as polycythemia vera <ref type="bibr" target="#b18">[19]</ref>, essential thrombocythemia <ref type="bibr" target="#b21">[22]</ref>, and myelofibrosis <ref type="bibr" target="#b22">[23]</ref>.</s><s>Painful leg ulcers are a rare but troublesome complication that has been described in patients receiving high-dose, long-term HU treatment, often leading to discontinuation of HU.</s><s>Although the exact mechanism for the development of this complication is still unclear, it has been hypothesized that inadvertent minor injury to the malleolar region that is inadequately repaired may jeopardize the regenerative potential of the epidermis.</s></p><p><s>To date, only single case reports <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25]</ref> or singlecenter experiences <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27]</ref> have been published regarding this phenomenon, with a reported incidence ranging from 5% to 10% of HU treated patients.</s><s>A 5% incidence of skin ulcers during HU treatment also has been reported in a large randomized trial in patients with essential thrombocythemia <ref type="bibr" target="#b27">[28]</ref>.</s><s>Currently, the occurrence of skin ulcers during HU treatment is considered as HU intolerance <ref type="bibr" target="#b28">[29]</ref>.</s></p><p><s>Our data suggested that during the first three weeks, the two groups showed no statistically significant difference in the area healed (%), but by week 4, patients receiving ZPO exhibited a significant improvement compared to the control group.</s><s>Moreover, all patients in the intervention group achieved complete healing at week 4.</s><s>In addition, the intervention group achieved healing significantly more rapidly than the control group, with significantly fewer pathological scars, highlighting the efficacy of ZPO in healing HU-induced leg ulcers.</s></p><p><s>The underlying mechanism for the ulcer healing effects of ZPO still remains unclear.</s><s>In chronic skin ulcer, intense and persistent inflammatory response, reduced angiogenesis and cell proliferation, decreased cell growth factors and collagen synthesis and degradation of excessive extracellular matrix all contribute to impairment of wound healing.</s><s>Amongst these, the regeneration of capillary and vascular network formation plays an important role.</s><s>As the most important regulatory factor of angiogenesis and neovascularization, vascular endothelial growth factor (VEGF) can stimulate the formation, proliferation, and migration of endothelial cells of the blood vessels <ref type="bibr" target="#b29">[30]</ref>.</s><s>The continuous secretion of VEGF plays a very important role in accelerating wound healing.</s><s>Another study conducted by our team on the treatment of nonhealing wounds after breast cancer operation showed that the expression of VEGF in wound tissues was upregulated in patients treated with ZPO (data not shown).</s><s>Glycyrrhiza uralensis Fisch, a component of ZPO, was reported to promote gastric ulcer healing by regulating inflammatory mediators <ref type="bibr" target="#b15">[16]</ref>.</s><s>We speculate that the ZPO may improve wound healing via multiple mechanisms including modulating the content of VEGF or inflammatory mediators.</s><s>The levels of these molecules were not investigated in the current study and are worthy of further exploration.</s></p><p><s>Given the limited treatment options for HU-induced leg ulcers, our current randomized controlled trial demonstrated that the ZPO offers an effective therapeutic option for HUinduced leg ulcers.</s><s>The study has certain limitations.</s><s>The study population is relatively small, given the rarity of the condition.</s><s>In addition, our hospital is a tertiary care center and the findings of the study may not be applicable to primary care settings.</s><s>Furthermore, a mixture of medicinal herbs was used in the ZPO, rendering it difficult to attribute the actions of the ointment to any particular compound.</s></p><p><s>In conclusion, our randomized controlled trial demonstrates that the ZPO is effective in promoting the healing of HU-induced leg ulcers in patients with myeloproliferative neoplasms, providing a therapeutic option for a condition that is recalcitrant to conventional therapy.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Abbreviations: ZPO, Zhangpi Ointment.</s></p></div></figDesc><graphic coords="4,101.16,74.36,396.97,369.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Abbreviations: ZPO, Zhangpi Ointment.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: Complete healing incidence during the overall observation period of eight weeks.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>6 EvidenceFigure 3 :</head><label>63</label><figDesc><div><p><s>Abbreviations: ZPO, Zhangpi Ointment.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 :</head><label>4</label><figDesc><div><p><s>Figure 4: Days to complete ulcer healing of the two groups.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Abbreviations: ZPO, Zhangpi Ointment.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 :</head><label>5</label><figDesc><div><p><s>Figure 5: Pathological scar formation after complete healing for the two groups.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 :</head><label>1</label><figDesc><div><p><s>The components of the Zhangpi Ointment and their pharmacological properties.</s></p></div></figDesc><table><row><cell>Herbal</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>components Chinese names Plant part used Category by TCM theory Phytochemical constituents Pharmacological action in wound healing</head><label></label><figDesc></figDesc><table><row><cell>Hemostatic function, anticoagulation,</cell><cell>inhibition of bacteria, anti-inflammation,</cell><cell>antioxidant, reducing swelling and pain</cell><cell>reduction</cell><cell cols="2">Anti-inflammation, inhibition of bacteria</cell><cell></cell><cell>Inhibition of platelet aggregation,</cell><cell>anti-thrombosis, analgesic action</cell><cell>Detoxification, anti-inflammation</cell><cell cols="2">Detoxification, anti-inflammation</cell><cell></cell><cell>Detoxification, anti-inflammation</cell><cell></cell><cell>Hemostatic function, promoting wound</cell><cell>healing, detoxification, astringent effect</cell><cell>Astringent effect, hemostatic function,</cell><cell>detoxification, inhibiting bacteria</cell></row><row><cell></cell><cell>Rhein, emodin, chrysophanol,</cell><cell>chrysaron, aloe-emodin, physcion</cell><cell>Shikonin, acetylshikonin,</cell><cell cols="2">ùõΩ-hydroxyisovalerylshikonin,</cell><cell>teracrylshikonin</cell><cell>Ferulic acid, succinic, nicotinic acid,</cell><cell>butylidenephthalide, folinic acid</cell><cell>Glycyrrhizic acid, liquiritin</cell><cell>ùõΩ-sitosterol, mannitol, stigmasterol,</cell><cell>campesterol, rehmannin</cell><cell>Cinnamic acid, betaine, kukoamine A,</cell><cell>lyciumin A, lyciumin B, ùõΩ-sitosterol,</cell><cell>linoleic acid, linolenic acid</cell><cell>Myosin, actin, tropomyosin,</cell><cell>hemoglobin, creatine, palmitic acid</cell><cell>Mercurous chloride (Hg 2 Cl 2 )</cell></row><row><cell></cell><cell cols="2">Purging drug</cell><cell></cell><cell cols="2">Heat-clearing drug</cell><cell></cell><cell>Blood tonifying</cell><cell>drug</cell><cell>Heat-clearing drug</cell><cell cols="2">Heat-clearing drug</cell><cell></cell><cell>Heat-clearing drug</cell><cell></cell><cell cols="2">Wound healing</cell><cell>Wound healing</cell></row><row><cell></cell><cell cols="2">Root</cell><cell></cell><cell cols="2">Root</cell><cell></cell><cell cols="2">Root</cell><cell>Root</cell><cell cols="2">Root</cell><cell></cell><cell>Root</cell><cell></cell><cell cols="2">-</cell><cell>-</cell></row><row><cell></cell><cell cols="2">Dahuang</cell><cell></cell><cell cols="2">Zicao</cell><cell></cell><cell cols="2">Danggui</cell><cell>Gancao</cell><cell cols="2">Shengdihuang</cell><cell></cell><cell>Digupi</cell><cell></cell><cell cols="2">Xiangpifen</cell><cell>Qingfen</cell></row><row><cell></cell><cell cols="2">Rheum officinale Baill</cell><cell cols="2">Arnebia euchroma (Royle)</cell><cell cols="2">Johnst.</cell><cell>Angelica sinensis (Oliv.)</cell><cell>Diels</cell><cell>Glycyrrhiza uralensis Fisch</cell><cell>Rehmannia glutinosa</cell><cell>Libosch</cell><cell></cell><cell>Cortex Lycii</cell><cell></cell><cell cols="2">Rubber powder</cell><cell>Calomel</cell></row></table><note><p><s>Abbreviations:TCM, traditional Chinese medicine.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 :</head><label>2</label><figDesc><div><p><s>Baseline characteristics of the patients.</s></p></div></figDesc><table><row><cell>Characteristic</cell></row></table><note><p><s>Abbreviations: ZPO, Zhangpi Ointment; BMI, Body Mass Index; HU, hydroxyurea; NRS, Numerical Rating Scale.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 :</head><label>3</label><figDesc><div><p><s>Adverse events in the study population.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="2">Intervention (%)</cell><cell></cell><cell></cell><cell cols="2">Control (%)</cell><cell></cell></row><row><cell></cell><cell>Grade 1</cell><cell>Grade 2</cell><cell>Grade 3</cell><cell>Grade 4</cell><cell>Grade 1</cell><cell>Grade 2</cell><cell>Grade 3</cell><cell>Grade 4</cell></row><row><cell>Cutaneous</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Allergy</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Infections</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>1(3.85)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Bleeding</cell><cell>1(4.35)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>1(3.85)</cell><cell>1(3.85)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Dry skin</cell><cell>0(0.00)</cell><cell>1(4.35)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>1(3.85)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Skin tenderness</cell><cell>1(4.35)</cell><cell>1(4.35)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>2(7.69)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Non-cutaneous</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Renal disorders</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row><row><cell>Liver disorders</cell><cell>1(4.35)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell><cell>1(3.85)</cell><cell>0(0.00)</cell><cell>0(0.00)</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>MPNs: Myeloproliferative neoplasms HU: Hydroxyurea ZPO: Zhangpi Ointment VEGF: Vascular endothelial growth factor.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Availability</head><p><s>The data used to support the findings of this study are available from the corresponding author upon request.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest</head><p><s>All authors have no conflicts of interest to declare.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' Contributions</head><p><s>Yu-yang Pang, Yan Li, Gang Kui, and Yong Tang contributed equally to this work.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stem Cells International</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Further Studies on the Mechanism of Action of Hydroxyurea</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Yarbro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1082" to="1087" />
			<date type="published" when="1968">1968</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Najean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-D</forename><surname>Rain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3370" to="3377" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Causes, investigation and treatment of leg ulceration</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mekkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A M</forename><surname>Loots</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Van Der Wal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Bos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="388" to="401" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<author>
			<persName><forename type="first">E</forename><surname>Antonioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Guglielmelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pieri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Hydroxyurearelated toxicity in 3,411 patients with Ph&apos;-negative MPN</title>
				<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="552" to="554" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Vasculitic leg ulcers in chronic myelogenous leukemia</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Silber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="869" to="872" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Antar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Ishak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">K</forename><surname>Otrock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hematology/Oncology and Stem Cell Therapy</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="166" to="169" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia</title>
		<author>
			<persName><forename type="first">E</forename><surname>Montefusco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Alimena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gastaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Carlesimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Valesini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mandelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">TUMORI</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="317" to="321" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Hydroxyurea-induced foot ulcer in a case of essential thrombocythaemia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ichioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sekiya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Wound Care</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="361" to="364" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Leg ulcers in patients with myeloproliferative disorders: Diseaseor treatment-related</title>
		<author>
			<persName><forename type="first">U</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banyai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>B√∂ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hafner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dermatology</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="45" to="48" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Leg ulcers associated with long-term hydroxyurea therapy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Weinlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Greil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kofler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fritsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Academy of Dermatology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="372" to="374" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Hydroxyurea induced-Leg ulcer in polycythemia vera</title>
		<author>
			<persName><forename type="first">A</forename><surname>Khaled</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">El</forename><surname>Guellali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>A√Øssaoui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="s">La Tunisie M√©dicale</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="292" to="294" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tateishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Onozawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shimizu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Dermato-Venereologica</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="373" to="374" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marciello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sandri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmaceutical Development and Technology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="415" to="422" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Hydroxyureainduced leg ulcers treated with a protease-modulating matrix</title>
		<author>
			<persName><forename type="first">M</forename><surname>Romanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Romanelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Dermatology</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1310" to="1313" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Hydroxyurea-induced foot ulcer successfully treated with a topical basic fibroblast growth factor product</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Aragane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Isogai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kawada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tezuka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Dermatology</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="599" to="600" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Anti-ulcer effect and potential mechanism of licoflavone by regulating inflammation mediators and amino acid metabolism</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-R</forename><surname>Bao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="page" from="175" to="182" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Effect of polysaccharides from Angelica sinensis on gastric ulcer healing</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">N</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">Y</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sciences</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="925" to="932" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Anti-oxidative, antisecretory and anti-inflammatory activities of the extract from the root bark of Lycium chinense (Cortex Lycii) against gastric ulcer in mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Olatunji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Natural Medicines</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="610" to="619" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Eneroth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Van Houtum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes/Metabolism Research and Reviews</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S76" to="S80" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A systematic review of the quality of burn scar rating scales for clinical and research use</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Tyack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spinks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wasiak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Burns</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="6" to="18" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor</title>
		<author>
			<persName><forename type="first">F</forename><surname>Stagno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Guglielmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Consoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fiumara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Giustolisi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1479" to="1480" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation</title>
		<author>
			<persName><forename type="first">T</forename><surname>Barbui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Barosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grossi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="215" to="232" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">How I treat symptomatic splenomegaly in patients with myelofibrosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Mesa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="5394" to="5400" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Leg ulcers associated with hydroxyurea therapy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sastre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bravo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tembr√°s</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>G√≥mez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ulibarrena</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2003">2003</date>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page">M01</biblScope>
		</imprint>
	</monogr>
	<note>Haematologica</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A hydroxyurea-induced Leg ulcer</title>
		<author>
			<persName><forename type="first">S.-W</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-K</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-K</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-S</forename><surname>Sung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annals of Dermatology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="39" to="41" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Randi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ruzzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Luzzatto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tezza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Girolami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fabris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="261" to="262" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Leg ulcers in elderly on hydroxyurea: A single center experience in ph-myeloproliferative disorders and review of literature</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ruzzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Randi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tezza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Luzzatto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scandellari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fabris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging Clinical and Experimental Research</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="187" to="190" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Buck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="45" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: Results of a European LeukemiaNet (ELN) consensus process</title>
		<author>
			<persName><forename type="first">G</forename><surname>Barosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Birgegard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Finazzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Haematology</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="961" to="963" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Hydroxycarbamide: a user&apos;s guide for chronic myeloproliferative disorders</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Spivak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hasselbalch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Review of Anticancer Therapy</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="403" to="414" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
